Legal & General Group Plc
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 764068
London, X0
Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,504,788
+$783,870 QoQ
Shares Held
96,259
-0.9% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 328 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. HRMY ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in HRMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,504,788 | 96,259 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,720,918 | 97,141 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $4,009,663 | 107,153 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,112,983 | 112,953 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,631,850 | 114,932 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,660,491 | 110,289 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,024,558 | 116,959 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,573,600 | 89,340 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $2,781,522 | 92,195 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $3,153,396 | 93,907 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $3,048,021 | 94,366 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $3,227,287 | 98,483 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,125,786 | 88,826 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,631,785 | 80,606 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,497,978 | 81,633 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,484,736 | 78,680 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,947,072 | 60,428 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $2,544,735 | 52,307 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,244,099 | 52,629 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $246,767 | 6,438 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $87,455 | 3,098 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $20,848 | 631 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $22,810 | 631 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||